Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Minority Interest (2021 - 2026)

Bioventus filings provide 5 years of Minority Interest readings, the most recent being $44.3 million for Q4 2025.

  • On a quarterly basis, Minority Interest rose 17.73% to $44.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.3 million, a 17.73% increase, with the full-year FY2025 number at $44.3 million, up 17.73% from a year prior.
  • Minority Interest hit $44.3 million in Q4 2025 for Bioventus, up from $41.2 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $140.7 million in Q4 2021 to a low of $35.7 million in Q4 2022.
  • Median Minority Interest over the past 5 years was $48.2 million (2023), compared with a mean of $58.1 million.
  • Biggest five-year swings in Minority Interest: tumbled 54.16% in 2022 and later skyrocketed 36.86% in 2023.
  • Bioventus' Minority Interest stood at $140.7 million in 2021, then tumbled by 38.17% to $87.0 million in 2022, then crashed by 45.36% to $47.5 million in 2023, then decreased by 20.75% to $37.7 million in 2024, then grew by 17.73% to $44.3 million in 2025.
  • The last three reported values for Minority Interest were $44.3 million (Q4 2025), $41.2 million (Q3 2025), and $40.1 million (Q2 2025) per Business Quant data.